# Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-feasibility-of-crispr-edited-t-cells-in-patients-with-refractory-non/

## Facts

| Field | Value |
| --- | --- |
| Author Names | You Lü,Jianxin Xue,Tao Deng,Xiaojuan Zhou,Kun Yu,Lei Deng,Meijuan Huang,Xin Yi,Maozhi Liang,Yu Wang,Haige Shen,Ruizhan Tong,Wenbo Wang,Li Li,Jin Sook Song,Jing Li,Xiaoxing Su,Zhenyu Ding,Youling Gong,Jiang Zhu,Yongsheng Wang,Bingwen Zou,Yan Zhang,Yanying Li,Lin Zhou,Yongmei Liu,Min Yu,Yuqi Wang,Xuanwei Zhang,Limei Yin,Xuefeng Xia,Yong Zeng,Qiao Zhou,Binwu Ying,Chong Chen,Yuquan Wei,Weimin Li,Tony Mok |
| Citations | 544 |
| DOI | 10.1038/s41591-020-0840-5 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3019413961 |
| PMID | 32341578 |
| Type | article |
| Year | 2020 |

## Paper authors

- [You Lü](https://scholariq.org/researchers/you-lu/)
- [Xiaojuan Zhou](https://scholariq.org/researchers/xiaojuan-zhou/)
- [Weimin Li](https://scholariq.org/researchers/weimin-li/)
- [Xuefeng Xia](https://scholariq.org/researchers/xuefeng-xia/)
- [Jianxin Xue](https://scholariq.org/researchers/jianxin-xue/)
- [Yan Zhang](https://scholariq.org/researchers/yan-zhang-2/)

## Paper journal

- [Nature Medicine](https://scholariq.org/journals/nature-medicine/)

## Paper primary topic

- [CRISPR and Genetic Engineering](https://scholariq.org/topics/crispr-and-genetic-engineering/)

## Paper topics

- [CRISPR and Genetic Engineering](https://scholariq.org/topics/crispr-and-genetic-engineering/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Virus-based gene therapy research](https://scholariq.org/topics/virus-based-gene-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.